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Background—Cross-sectional studies show that human immunodeficiency virus (HIV) stigma
is negatively correlated with social support.
Purpose—The purpose of this study is to examine the bidirectional relationship between social
support and HIV stigma.
Methods—We collected quarterly data from a cohort of 422 people living with HIV in Uganda,
followed for a median of 2.1 years. We used multilevel regression to model the contemporaneous
and 3-month-lagged associations between social support and both enacted and internalized stigma.
Results—Lagged enacted stigma was negatively correlated with emotional and instrumental
social support, and lagged instrumental social support was negatively correlated with enacted
stigma. Internalized stigma and emotional social support had reciprocal lagged associations.
Conclusions—Interventions to reduce enacted stigma may strengthen social support for people
living with HIV. Improved social support may in turn have a protective influence against future
enacted and internalized stigma.
Keywords
HIV/AIDS; Stigma; Social support; Uganda
Introduction
Human immunodeficiency virus (HIV) stigma is a well-documented barrier to the health and
well-being of people living with HIV. As described by Goffman [1], stigma is a discrediting
attribute that reduces a person from a whole person to a tainted or discounted person. HIV
stigma has been associated with delaying or avoidance of HIV testing [2–4], poor adherence
to antiretroviral therapy (ART) [5, 6], increased risk behaviors [7], and poor engagement
with care [8]. In addition, people living with HIV experience numerous mental and
psychological sequelae of stigma, including stress, fear, anxiety, and depression [9–12].
Recent studies have shown that people living with HIV who report experiences of HIV
stigma also report lower levels of perceived social support [12–15]. Social support refers to
the provision of psychological and material resources by people within one's social network
[16]. The finding that people living with HIV who are more vulnerable to stigma also have
less access to social resources has profound public health consequences because social
support has been associated with powerful health benefits for people living with HIV. These
include less depression [10], positive health behaviors such as adherence to medication [6],
improved coping and quality of life [17], and slower progression of disease to AIDS [18].
These benefits have been understood in the context of a larger body of literature examining
social support and health. The mechanisms underlying the health benefits of social support
have been attributed to its various functional components, which include informational,
emotional (e.g., caring, empathy), and instrumental support (e.g., financial assistance or help
with tasks) [16, 19, 20]. Starting with the 1979 study by Berkman and Syme [21] who
showed that social isolation was a significant risk factor for mortality, research on social
support and health has shown that social support fosters psychological well-being, enhances
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self-esteem and self-efficacy, reduces physiological arousal, and promotes functional and
adaptive coping with stressors [20, 22–24]. These psychosocial benefits translate to
improved health through decreased physiological stress responses, engagement in health-
promoting behaviors, and avoidance of health-damaging behaviors [20, 22–24].
Conceptual Model
Based on evidence that stigma is a multidimensional construct, researchers have developed
and utilized a conceptual model that separates the experience of stigma into interpersonal
and intrapersonal experiences. The interpersonal experience of stigma is called enacted
stigma and is defined as discriminatory behaviors directed towards people with the
stigmatized condition [25]. The intrapersonal experience of stigma is called internalized
stigma and is the endorsement and internalization of negative evaluations held by others
[26–28]. Models of stigma describe how people internalize stigma when they perceive the
negative stereotypes to be legitimate, and suffer negative cognitive, emotional and
behavioral consequences, such as ambivalence about identity, low-self esteem, and low self-
efficacy [26, 27, 29, 30]. While the terminology may vary, these concepts of enacted and
internalized stigma are used widely in other health conditions, such as obesity [31] and
mental health [32], to understand the differential effects of these two dimensions of stigma
on health behaviors and outcomes.
Historically, models of stigma have predominantly focused on individuals—the stigmatized
person and the stigmatizing person—and their cognitive, affective, and behavioral processes,
but recent sociological and anthropological work have proposed to embed stigma in the
social space [33]. These works demonstrate that stigma is a social experience in which the
effects of stigma extend to the affected individual's social ties, and in which those social ties
in turn shape the experience of the stigmatized individual. Qualitative studies have
demonstrated that family members of people living with HIV become reluctant to disclose to
others the serostatus of the affected family member for fear of discrimination and loss of
social standing in their community [9, 34]. Furthermore, close social ties can often be the
source of stigmatizing attitudes and actions. People living with HIV experience avoidance,
ostracism, and verbal insults from their friends and family [9], and some studies theorize
that the enactment of stigma is in response to the devalued status they acquire through
association with the stigmatized person [34]. While HIV stigma strains existing close
relationships, it can also profoundly limit the ability of people living with HIV to seek new
relationships. One proposed mechanism is the lack of disclosure. Disclosure is essential for
people to receive social support; yet, fear of discrimination prevents people living with HIV
from disclosing their status [35, 36], and the higher their level of internalized stigma, the
more likely they are to avoid disclosure and interactions with others [11, 37]. Finally, HIV
stigma has been correlated with depression [10, 12], which may further limit the capacity of
people living with HIV to form and maintain social relationships. These mechanisms take on
particular significance in Uganda, where HIV stigma is a prominent concern among people
living with HIV with profound implications for their social experience. In one study
conducted in Uganda, fear of HIV serostatus disclosure was the most common concern
voiced by people living with HIV and was noted by more participants than concerns about
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lack of food [38], which is notable in light of the high prevalence of food insecurity among
people living with HIV [39, 40].
Recent findings linking social support and HIV stigma, though suggestive, have been based
on cross-sectional data [12–14] or data from two time points [15], limiting our ability to
illuminate the dynamic relationship between social support and HIV stigma. Furthermore,
these studies have not examined how the interpersonal and intrapersonal dimensions of HIV
stigma could differentially affect the social experience of people living with HIV. To
address these gaps in our current understanding of HIV stigma and social support, we
examined the dynamic relationship between two dimensions of social support and two
dimensions of HIV stigma using longitudinal data collected from people living with HIV
receiving ART at a public hospital in rural southwestern Uganda. The primary aim of our
analysis was to use time-lagged models to understand how the interpersonal and
intrapersonal experiences of HIV stigma shape the social support networks of people living
with HIV in rural Uganda, and to understand how these relationships in turn shape their
experience of HIV stigma.
Methods
Setting and Participants
We used data from an ongoing, prospective cohort of people living with HIV initiating ART
in rural Uganda. Eligibility criteria included having no prior history of treatment with ART,
being over 18 years of age, and living within 20 km of the Immune Suppression Syndrome
(ISS) Clinic at the Mbarara Regional Referral Hospital. The ISS Clinic is located in Mbarara
District, 275 km southwest of Kampala, and provides free ART for people living with HIV
in southwestern Uganda, Rwanda, and the Democratic Republic of Congo [41]. Most
participants live in outlying villages surrounding the town of Mbarara, spending an hour on
average to travel to the clinic by paid motorbike and on foot [42]; live in multigenerational
households with other relatives living close by; engage in subsistence agriculture; and
frequently interact with other members of the community through religious services,
agricultural work, and community gatherings. The predominant ethnic group is Ankole, and
the local language is Runyankole.
Our analyses are based on data from participants who were enrolled into the cohort from
2007 through 2010. Survey questions were translated into Runyankole, back-translated into
English, further modified through focus groups with key informants, and pilot-tested to
ensure clarity and relevance. Trained research assistants who spoke Runyankole interviewed
participants every 3 months in a private room at a research office near the ISS Clinic. Each
survey took approximately 1 h to complete. Informed consent was obtained from all study
participants. Ethics approval for all study procedures was obtained by the Committee on
Human Research, University of California at San Francisco; the Partners Human Research
Committee at Massachusetts General Hospital; and the Institutional Ethical Review
Committee, Mbarara University of Science and Technology. Consistent with national
guidelines, we received clearance for the study from the Uganda National Council for
Science and Technology and from the Research Secretariat in the Office of the President.
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The four variables of interest were emotional social support, instrumental social support,
internalized stigma, and enacted stigma. We measured social support using the Social
Support Scale [43], which contains six items on emotional support and four items on
instrumental social support. This scale was adapted from the Duke/University of North
Carolina Functional Social Support Questionnaire, which was designed to measure multiple
dimensions of social support among patients in a primary care setting [44]. Higher scores
reflect higher levels of social support.
We measured internalized HIV stigma using the Internalized AIDS-Related Stigma Scale,
which contains six items corresponding to the guilt, shame, and worthlessness described in
Goffman's conceptualization of stigma [45, 46]. The internalized stigma scale has
demonstrated good internal reliability, a coherent internal structure, and good construct
validity among people living with HIV in rural Uganda [47]. To measure enacted stigma, we
asked participants about whether they had experienced ten different discriminatory events in
the past 3 months as a result of their HIV status, such as abandonment, housing, property
loss, or physical violence (see Electronic Supplementary Material). These questions were
adapted from a previous publication by Nyblade et al. [48]. We created an enacted stigma
index by constructing a total count of the different types of discriminatory events
experienced, with higher index scores indicating greater intensity of enacted stigma. Of note,
we did not have any a priori expectation that the variables would be internally consistent
because these different events are diverse in both severity as well as potential drivers.
Nonetheless, for the sake of comparison with our other variables of interest, we calculated
the reliability of the index at baseline.
Statistical Analysis
In our regression models, we adjusted for baseline and quarterly health status using the
Medical Outcome Study-HIV (MOS-HIV) Physical Health Summary (PHS) [49, 50] and
CD4+ T-lymphocyte cell count. A higher PHS score reflects a better health status. Because
prior studies have shown that both HIV stigma and low social support are associated with
depression [10, 12], we also adjusted for depression symptom severity. We measured
depression symptom severity using a version of the 15-item Hopkins Symptom Checklist for
Depression [51] that was adapted to the local context with the addition of a 16th item,
“feeling like I don't care about my health” [10, 52]. We restricted our calculation of the
score to the 12 affective items in light of prior research suggesting that the somatic items
overlap with symptoms of HIV infection and may inflate the prevalence of depression
among people living with HIV [53, 54]. Participants were classified as having probable
depression based on the conventional threshold score of 1.75 [55].
We adjusted for a range of other baseline (time-invariant) demographic and socioeconomic
covariates with potential for influencing the relationships among stigma, social support, and
health. We measured household wealth using a household asset index [56], which was
entered into the models as a continuous variable, with higher values of the asset index
indicating greater household wealth relative to other households in the sample. We also
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adjusted for baseline age, sex, educational attainment, and marital status. Time on treatment
was measured in years since starting ART.
Data analysis was conducted using SAS statistical software (version 9.2, SAS Institute Inc.,
Cary, NC, USA). We employed multilevel modeling to address the lack of independence
among residuals in the hierarchically structured data. Since our data consisted of measures
that are nested within individuals, measures from the same individual may share common,
unobserved characteristics that may affect the outcomes of interest. Our modeling technique
allowed us to separate the composite residual into two parts: a measure-level residual unique
to the particular time at which the survey was conducted, and an individual-level residual
unique to a particular individual (but not to a particular time). We used multilevel models
for change, in which the models are specified by simultaneously postulating a pair of
subsidiary models: a level-1 submodel that describes how each individual changes over
time, and a level-2 submodel that describes how these changes differ across individuals [57].
Our level-1 submodel stipulated that the trajectories of stigma and social support are linear
with time.
To examine the effects of each of the two social support dimensions on each of the two
stigma dimensions and, reciprocally, the effects of each of the stigma dimensions on each of
the social support dimensions, we specified eight contemporaneous regression models. First,
in two regression models, internalized stigma was specified as the outcome, with
instrumental and emotional social support alternately included as the main predictors (while
adjusting for covariates). Second, enacted stigma was specified as the outcome, with
instrumental and emotional social support alternately included as the main predictors. Third,
emotional social support was specified as the outcome in two regression models, with
internalized and enacted stigma alternately included as the main predictors. Finally,
instrumental social support was specified as the outcome, with internalized and enacted
stigma alternately included as the main predictors. We also fitted lagged-covariate models,
in which each of the predictors of interest were lagged by 3 months, adjusting for covariates
and the lagged outcome variable. In total, we fitted 16 regression models: 8 models in which
the explanatory variables of interest were measured contemporaneously with the outcomes
and 8 models in which the explanatory variables were measured with a 3-month lag.
Results
Table 1 presents the baseline demographic characteristics of the 422 participants. The
average age of participants at baseline was 35 years, and they were enrolled in the study for
a mean of 2.3 years (median of 2.1 years). The majority of participants [298 (71 %)] were
female. Approximately half were married and half were widowed or divorced. Most [357
(85 %)] had completed primary school or more. The mean internalized stigma score at
baseline was 1.3 points (median, 1.0; SD, 1.5) with a range of 0–6, the mean enacted stigma
score was 0.4 points (median, 0; SD, 0.8) with a range of 0–7, the mean emotional social
support score was 3.8 points (median, 4; SD, 0.4), and the mean instrumental social support
score was 3.6 (median, 4; SD, 0.6). The mean CD4 count at baseline was 230 cells/mL
(median, 204; SD, 149). Sixteen percent of participants screened positive for probable
depression at baseline.
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Throughout the study period, the most frequently endorsed item on the internalized stigma
scale was “difficult to tell other people about my HIV status,” (852 responses, 29 % of all
responses), followed by “I hide my HIV status from others,” [832 (28 %)]. Similarly, the
most frequently endorsed form of enacted stigma was “being gossiped about,” [768 (25 %)]
followed by “being teased or insulted” [201 (7 %)].
At baseline, the Cronbach's alpha of the internalized stigma scale was 0.73. Both social
support subscales showed good internal reliability at baseline (instrumental social support
Cronbach's alpha=0.87, emotional social support Cronbach's alpha=0.89), as did the social
support scale as a whole (Cronbach's alpha=0.91). The Cronbach's alpha for the enacted
stigma index was 0.56.
Preliminary analyses supported the use of multilevel models for change and lagged models.
Briefly, empirical growth plots showed substantive changes within individuals over time in
enacted stigma, internalized stigma, emotional social support, and instrumental social
support. Furthermore, intraclass correlation coefficients indicated large variability within
individuals over time. The intraclass correlation for emotional social support was 0.53,
indicating that an estimated 53 % of the total variation in social support was attributable to
differences between individuals while 47 % was attributable to variability over time within
individuals. Overall, over the entire study period, 198 (47 %) participants had a negative
slope over time for internalized stigma (i.e., indicating that internalized stigma decreased
over time) while 69 (16 %) had a slope of zero and 155 (37 %) had a positive slope.
Averaged across all participants, internalized stigma decreased at a rate of 0.13 points per
year. Similarly, the intraclass correlations for enacted stigma, emotional social support, and
instrumental social support were 0.74, 0.83, and 0.72, respectively.
Internalized Stigma
In the contemporaneous models specifying internalized stigma as the outcome, we found no
relationship between internalized stigma and either emotional or instrumental social support
(Table 2). In the lagged-covariate models, we found an inverse relationship between
internalized stigma and lagged emotional social support. A 1-point increase in emotional
social support was associated with a 0.13-point decrease in subsequent internalized stigma
(95 % CI, −0.25 to −0.005), a 10 % relative difference compared to the baseline value.
There was no statistically significant association between internalized stigma and lagged
instrumental social support. In all four models, higher levels of self-reported physical health
and lower levels of depression were correlated with lower levels of internalized stigma.
Enacted Stigma
In the contemporaneous models with enacted stigma as the outcome, we found that
individuals with higher levels of emotional social support or instrumental social support
reported lower levels of enacted stigma (Table 3). A 1-point increase in emotional social
support was correlated with a 0.30-point decrease in enacted stigma (95 % CI, −0.37 to
−0.24), and a 1-point increase in instrumental social support was correlated with a 0.16-
point decrease in enacted stigma (95 % CI, −0.21 to −0.12). In the lagged-covariate models,
we found that lagged instrumental social support was negatively correlated with subsequent
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enacted stigma (b =−0.07, 95 % CI −0.11, −0.03), but we found no statistically significant
relationship between lagged emotional social support and subsequent enacted stigma. A 1-
point increase in lagged instrumental social support was correlated with a 0.07-point
decrease in subsequent enacted stigma. In all four models, higher levels of education,
wealth, and physical health status were consistently associated with lower levels of enacted
stigma.
Emotional Social Support
In the contemporaneous models with emotional social support as the outcome, we found that
individuals with higher levels of internalized stigma or enacted stigma reported lower levels
of emotional social support (Table 4). Each 1-point increase in the internalized stigma scale
was associated with a 0.014-point decrease in the emotional social support scale (95 % CI,
−0.024 to −0.003). Each one-point increase in enacted stigma was correlated with a 0.095-
point decrease in emotional social support (95 % CI, −0.11 to −0.075). In the lagged-
covariate models, lagged internalized stigma was negatively correlated with subsequent
emotional social support (b =−0.016; 95 % CI, −0.026 to −0.005), and lagged enacted
stigma was negatively correlated with subsequent emotional support (b =−0.032; 95 % CI,
−0.062 to −0.01). In all four models, higher levels of wealth and physical health status were
correlated with higher levels of emotional social support.
Instrumental Social Support
In the contemporaneous models with instrumental social support as outcome, we found that
individuals who reported higher levels of enacted stigma reported lower levels of
instrumental social support, but we found no statistically significant relationship between
internalized stigma and instrumental social support (Table 5). A 1-point increase in enacted
stigma was associated with a 0.11-point decrease in instrumental social support (95 % CI,
−0.14 to −0.08). In the lagged-covariate models, lagged enacted stigma was negatively
correlated with subsequent instrumental social support (b =−0.032; 95 % CI, −0.062 to
−0.001), but lagged internalized stigma did not have a statistically significant relationship
with subsequent instrumental social support. In all four models, higher levels of education,
wealth, and physical health status were correlated with higher levels of instrumental social
support, while higher CD4 counts were associated with lower levels of instrumental social
support.
We further examined this apparently paradoxical relationship between instrumental social
support and CD4 count. We estimated the effect of the two dimensions of stigma and two
dimensions of social support on CD4 count using four multilevel modeling controlling for
covariates, and found no statistically significant relationship between internalized stigma,
enacted stigma, or emotional social support with CD4 count (data not shown). However, we
found that individuals who reported higher levels of instrumental social support had lower
CD4 counts and that a 1-point increase in instrumental social support was correlated with a
14.7 decrease in CD4 count (95 % CI, −22.6 to −6.9). We conducted exploratory subgroup
analyses to further explore this finding and estimated the effects of interactions between
sociodemographic variables and instrumental social support. We found that the joint
interaction between gender and instrumental social support did not have a statistically
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significant relationship with CD4 count, but that the joint interaction of education and
instrumental social support (b =−21.7; 95 % CI, −42.3 to −1.1) as well as the joint
interaction of marital status and instrumental social support (b =−18.6; 95 % CI, −34.2 to
−3.0) were statistically significant predictors of CD4 count. We also estimated separate
multilevel models with CD4 count as the outcome and instrumental social support as the
main predictor for men and women, married and unmarried participants, and participants
with and without education. We found that instrumental social support was a statistically
significant predictor of CD4 count for men (b =−22.0; 95 % CI, −38.4 to −5.6), women (b =
−12.0; 95 % CI, −21.0 to −3.1), married participants (b = −26.0; 95 % CI, −38.2 to −13.8),
and educated participants (b =−0.19; 95 % CI, −27.1 to −10.0), but not among unmarried
participants or participants without a formal education.
Figure 1 summarizes the lagged relationships between the two dimensions of stigma and two
dimensions of social support. In summary, low levels of instrumental social support are
associated with high subsequent levels of enacted stigma, which in turn are associated with
lower subsequent instrumental social support. High levels of enacted stigma are associated
with low subsequent levels of emotional support. Low levels of emotional social support are
associated with high subsequent levels of internalized stigma, which in turn are associated
with even lower subsequent levels of emotional support.
Discussion
In this longitudinal analysis of data from people living with HIV initiating ART in rural
Uganda, we found evidence that enacted stigma may compromise the ability to access both
emotional and instrumental support from friends and family. We also found that internalized
stigma may compromise the ability to access emotional support. At the same time, we found
that instrumental social support was protective against future experiences of enacted stigma
but not against internalized stigma. Finally, emotional social support was protective against
future internalization of stigma, but not future experiences of enacted stigma. The estimated
associations were strong, large in magnitude, and robust to lagged specifications that
ensured a temporal ordering between the exposures and outcomes.
One of our primary findings was that the relationship between enacted stigma and social
support was bidirectional. Lagged enacted stigma had an inverse association with both
emotional and instrumental social support, indicating that people living with HIV who
experienced discrimination lost social support. Lagged instrumental social support had an
inverse association with subsequent enacted stigma, indicating that people living with HIV
who had less access to instrumental social support experienced more subsequent
discrimination. These findings suggest that enacted stigma may trigger a vicious cycle, in
which friends and family of people living with HIV abandon the HIV-affected person, and
themselves become perpetrators of discrimination toward people living with HIV. One
explanation may be that friends and family members become targets of discrimination by
association. Goffman [1] describes this stigma by association, called courtesy stigma, as the
process in which people who are “related through the social structure to a stigmatized
individual…are all obliged to share some of the discredit of the stigmatized person” (p. 30).
Goffman [1] further added that courtesy stigma “provides a reason why such relations tend
Takada et al. Page 9






















either to be avoided or to be terminated” (p. 30). Bogart and colleagues [9] similarly
reported that people living with HIVexperience avoidance and ostracism by family members
and friends, as well as overt acts of discrimination or hurtful remarks from those who
remained in contact. Yang and colleagues [34], using the example of mental illness in Hong
Kong, proposed that stigma threatens the moral standing of the family and friends, and the
family members' fear of social contamination and loss of face motivated them to abandon
and discriminate against their ill family member.
A second primary finding of our study was that there was an inverse and bidirectional
relationship between emotional social support and internalized stigma. The inverse
association between emotional support and reduced subsequent internalized stigma is
consistent with previously published findings from cross-sectional studies [12, 13, 15, 32].
The social cognitive behavioral model of internalized stigma holds that stigmatized people
are more likely to endorse demeaning beliefs when they blame themselves (instead of
broader social processes) for negative evaluations or when they do not have positive self-
perceptions [26]. Having emotionally supportive family and friends may help decrease the
perceived legitimacy of negative evaluations and help people living with HIV develop a
more positive sense of self, leading to less internalization of stigma.
Conversely, lagged internalized stigma was inversely associated with emotional social
support, indicating that people living with HIV who internalize stigma are less able to have
supportive relationships with friends and family. This is consistent with reports that people
with high internalized stigma are less likely to disclose their HIV status to their friends and
family or to solicit support from them [12, 37]. Internalized stigma has also been associated
with depression [10, 12], which could also compromise the affected persons' effectiveness in
maintaining supportive relationships. Furthermore, caring for people living with HIV exerts
substantive physical and psychological burdens on their caregivers, particularly in the
setting of depression [58]. This could result in a negative “feedback loop” of social support
[23], in which the strain of supporting a person with a serious illness results in caregivers
withdrawing and severing the relationship in order to cope with the strain.
How can we understand why individuals living with HIV who report high levels of
perceived instrumental social support subsequently report low levels of enacted stigma, but
not internalized stigma, while those who report high levels of emotional social support
subsequently report low levels of internalized stigma, but not enacted stigma? We
hypothesize that having friends and family who provide tangible help with tasks and
finances can protect the person from becoming targets of external, visible acts of
discrimination and insults. However, such transactional relationships may not be as helpful
as emotionally supportive relationships in protecting people living with HIV from endorsing
negative views about themselves and losing self-esteem. While internalized stigma has been
implicated in loss of self-efficacy such as that required for the disclosure of HIV serostatus
to partners [27], the null association between lagged internalized stigma and instrumental
social support may reflect that this loss of self-efficacy is most relevant to intimate,
emotional relationships. Our results confirm the conceptual difference [11] between enacted
stigma and internalized stigma by showing that internalized and enacted stigma each
originate from different interpersonal processes.
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These findings suggest that people living with HIV who are most affected by HIV stigma
may suffer the additional burden of losing social support. The emotional and material
resources provided by social support are critical for people living with HIV in resource-poor
settings like Uganda, who must address day-to-day economic challenges while adhering to
ART, maintaining positive health behaviors, and coping with the burden of illness and
stigma. In one qualitative study of 252 individuals living with HIV in three sub-Saharan
African countries, social relationships were critical for maintaining ART adherence, not only
because individuals living with HIV relied on them for transport to clinic, encouragement,
and regular reminders but also because of the social expectations that created obligations for
people living with HIV to adhere [59].
We acknowledge several limitations of this study. First, our measures are self-reported and
therefore suffer challenges generic to all analyses based on self-reported data. Second, it is
difficult to disentangle the extent to which the estimated associations may simply reflect an
unmeasured common factor. However, in the lagged models, we examine determinants of
stigma or social support after adjusting for lagged values of the variables. Third, the
perception of social support may not correlate perfectly with the actual degree of social
support received. However, prior studies have demonstrated that perceived social support is
more predictive of health outcomes than actual social support for people living with HIV/
AIDS [60]. Fourth, our study sample consisted of individuals living with HIV who were
initiating ART. Given that stigma is known to compromise the ability of people living with
HIV to access and adhere to ART [6, 61], and given that access to ART has been shown to
lower stigma [62–64], it is likely that overall levels of internalized stigma were lower in our
sample compared to untreated individuals living with HIV. Because social support is also
known to be positively associated with treatment access [59], this could have biased our
estimates away from the null. Fifth, the enacted stigma index had a relatively low reliability,
which was expected given the diversity of behaviors included in the index. The lack of
internal consistency simply increases the amount of random noise so that regression models
in which enacted stigma was specified as the dependent variable would have yielded
estimates that were biased towards the null. The mean of the internalized stigma and enacted
stigma scores were low, but comparable to those found in the literature [45]. Finally, the cut-
off for the Hopkins Symptom Checklist used to determine probable depression is based on
studies conducted in Western populations, and we acknowledge that this specific cutoff has
not been validated in the Ugandan context.
Of note, we found that internalized stigma, enacted stigma, and emotional social support did
not have statistically significant associations with CD4 count and that instrumental social
support had an inverse association with CD4 count. This finding is paradoxical in that social
support is generally thought of as being linked with better ART adherence [6] and other
positive health behaviors. However, there are likely multiple pathways leading from social
support to improved health, so extrapolating a direct association from the data may not be
warranted. In addition, instrumental social support may not have uniformly beneficial effects
on health, especially in settings where the nature of the support does not meet the recipient’s
needs. For example, instrumental social support has been found to increase dependency and
disability among older adults [65] or worsen glycemic control among people with diabetes
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mellitus [66]. Further research is indicated to clarify these associations among people living
with HIV.
In summary, we found that enacted stigma may compromise the ability of people living with
HIV to access support from close social ties, and that instrumental social support may be
protective against future experiences of discrimination. We also found that emotional social
support may be protective against future internalization of stigma. Taken together, our
findings provide unique longitudinal evidence on the bidirectional relationships between
stigma and social support. They also suggest the potentially powerful impacts that
antistigma interventions may have on the lives of people living with HIV by interrupting the
vicious feedback loop between stigma and social isolation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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This figure represents the relationships between emotional support, instrumental support,
enacted stigma, and internalized stigma. The arrows indicate statistically significant lagged,
inverse associations, where the arrow points toward the construct that follows in temporal
sequence
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Table 1
Participant baseline characteristics (N =422)
Characteristic N (%) or mean (median)
Gender
 Female 298 (71 %)
 Male 124 (29 %)
Age (years) 35 (34)
Time in study (years) 2.3 (2.1)
Marital status
 Not married 238 (56 %)
 Married 184 (44 %)
Education
 None 65 (15 %)
 Primary or more 357 (85 %)
Internalized stigma 1.3 (1)
Enacted stigma 0.4 (0)
Emotional social support 3.8 (4)
Instrumental social support 3.6 (4)
CD4 count (cells/mL) 230 (204)
MOS-HIV Physical Health Summary 46 (49)
Probable depression 67 (16 %)
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Table 2
The contemporaneous and lagged effects of emotional social support and instrumental social support on
internalized stigma
Effect of emotional social support on internalized
stigma
Effect of instrumental social support on internalized
stigma
Contemporaneous Lagged Contemporaneous Lagged
Variables b (95 % confidence
interval [CI])
b (95 % CI) b (95 % CI) b (95 % CI)
Intercept 1.02 (0.41, 1.62)** 1.08 (0.49, 1.67)*** 0.95 (0.46, 1.44)*** 0.57 (0.12, 1.03)*
Emotional social support −0.082 (−0.20, 0.04) – – –
Instrumental social support – – −0.070 (−0.15, 0.01) –
Lagged emotional social
support
– −0.13 (−0.25, −0.005)* – –
Lagged instrumental social
support
– – – 0.0083 (−0.067, 0.084)
Lagged internalized stigma – 0.11 (0.077, 0.15)*** – 0.113 (0.078, 0.15)***
Time −0.08 (−0.12, 0) −0.058 (−0.13, 0.014) −0.088 (−0.17, −0.007)* −0.063 (−0.14, 0.009)
Gender
 Male Ref Ref Ref Ref
 Female 0.11 (−0.13, 0.35) 0.08 (−0.14, 0.30) 0.10 (−0.14, 0.35) 0.087 (−0.14, 0.31)
Age −0.013 (−0.026, 0) −0.012 (−0.023, 0) −0.013 (−0.026, 0.001) −0.012 (−0.024, 0.00)
Marital status
 Not married Ref Ref Ref Ref
 Married 0.032 (−0.13, 0.19) 0.005 (−0.15, 0.16) 0.030 (−0.13, 0.19) 0.0054 (−0.15, 0.16)
Education
 No school Ref Ref Ref Ref
 Primary school or more 0.057 (−0.23, 0.35) 0.11 (−0.16, 0.37) 0.063 (−0.23, 0.35) 0.10 (−0.16, 0.36)
Household asset wealth 0.075 (0, 0.15) 0.065 (−0.004, 0.13) 0.079 (0.003, 0.15)* 0.062 (−0.01, 0.13)
MOS-HIV Physical Health
Summary
−0.019 (−0.02, −0.01)*** −0.018 (−0.024,
−0.012) ***
−0.019 (−0.025, −0.013)*** −0.018 (−0.024, −0.012)***
CD4 count (per 100
cells/mL)
0.009 (−0.03, 0.45) 0.004 (−0.033, 0.040) 0.007 (−0.030, 0.044) 0.005 (−0.031, 0.042)
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Table 3
The contemporaneous and lagged effects of emotional social support and instrumental social support on
enacted stigma
Effect of emotional social support on enacted stigma Effect of instrumental social support on enacted stigma
Contemporaneous Lagged Contemporaneous Lagged
Variables b (95 % confidence interval
[CI])
b (95 % CI) b (95 % CI) b (95 % CI)
Intercept 1.74 (1.43, 2.05)*** 0.72 (0.41, 1.04)*** 1.16 (0.94, 1.39)*** 0.79 (0.57, 1.00)***
Emotional social support −0.30 (−0.37, −0.24)*** – – –
Instrumental social support – – −0.16 (−0.21, −0.12)*** –
Lagged emotional social
support
– −0.045 (−0.12, 0.03) – –
Lagged instrumental social
support
– – – −0.070 (−0.11, −0.03)**
Lagged enacted stigma – 0.046 (0.009, 0.083)* – 0.044 (0.007, 0.081)*
Time 0.004 (−0.04, 0.04) 0.006 (−0.033, 0.045) −0.0009 (−0.049, 0.032) 0.006 (−0.033, 0.044)
Gender
 Male Ref Ref Ref Ref
 Female 0.096 (0.003, 0.189)* 0.099 (0.006, 0.19)* 0.077 (−0.017, 0.17) 0.091 (−0.002, 0.18)
Age 0.001 (−0.004, 0.006) 0.001 (−0.004, 0.006) 0.002 (−0.004, 0.007) 0.001 (−0.004, 0.006)
Marital status
 Not married Ref Ref Ref Ref
 Married −0.031 (−0.11, 0.043) −0.037 (−0.11, 0.038) −0.034 (−0.11, 0.04) −0.038 (−0.11, 0.037)
Education
 No school Ref Ref Ref Ref
 Primary school or more −0.15 (−0.26, −0.04)** −0.014 (−0.25, −0.03)* −0.14 (−0.25, −0.03)* −0.13 (−0.24, −0.02)*
Household asset wealth −0.045 (−0.074, −0.016)** −0.049 (−0.078, −0.020)*** −0.039 (−0.068,−0.01)** −0.046 (−0.074, −0.017)**
MOS-HIV Physical Health
Summary
−0.009 (−0.012, −0.005)*** −0.010 (−0.013, −0.006)*** −0.009 (−0.012, −0.005)*** −0.009 (−0.013, −0.006)***
CD4 count (per 100
cells/mL)
0.004 (−0.015, 0.022) 0.006 (−0.013, 0.025) 0.0003 (−0.019, 0.019) 0.006 (−0.013, 0.025)
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Table 4
The contemporaneous and lagged effects internalized stigma and enacted stigma on emotional social support
Effect of internalized stigma on emotional social
support Effect of enacted stigma on emotional social support
Contemporaneous Lagged Contemporaneous Lagged
Variables b (95 % confidence
interval [CI])
b (95 % CI) b (95 % CI) b (95 % CI)
Intercept 3.81 (3.73, 3.89)*** 3.69 (3.52, 3.85)*** 3.85 (3.78, 3.93)*** 3.70 (3.44, 3.96)***
Internalized stigma −0.014 (−0.024, −0.003)* – – –
Enacted stigma – – −0.095 (−0.114, −0.075)*** –
Lagged internalized stigma – −0.016 (−0.026, −0.005)** – –
Lagged emotional social
support
– 0.035 (−0.003, 0.074) – 0.019 (−0.04, 0.077)
Lagged enacted stigma – – – −0.032 (−0.062, −0.001)*
Time −0.011 (−0.032, 0.010) −0.013 (−0.034, 0.008) −0.008 (−0.028, 0.012) −0.003 (−0.051, 0.046)
Gender
 Male Ref Ref Ref Ref
 Female −0.034 (−0.079, 0.012) −0.032 (−0.077, 0.013) −0.025 (−0.068, 0.017) −0.052, (−0.12, 0.020)
Age −0.0002 (−0.003, 0.002) 0.0001 (−0.002, 0.003) 0.0001 (−0.002, 0.002) 0.0003 (−0.003, 0.004)
Marital status
 Not married Ref Ref Ref Ref
 Married −0.004 (−0.042, 0.033) −0.007 (−0.044, 0.031) −0.009 (−0.044, 0.027) −0.039 (−0.101, 0.023)
Education
 No school Ref Ref Ref Ref
 Primary school or more 0.021 (−0.033, 0.074) 0.010 (−0.043, 0.063) 0.002 (−0.048, 0.053) 0.034 (−0.048, 0.116)
Household asset wealth 0.025 (0.011, 0.039) *** 0.025 (0.011, 0.039)*** 0.020 (0.007, 0.033)** 0.002 (0.000, 0.045)*
MOS-HIV Physical Health
Summary
0.002 (0.001, 0.004)** 0.003 (0.001, 0.004)** 0.002 (0.00, 0.004)* 0.003 (0.0004, 0.006)*
CD4 (per 100 cells/mL) −0.009 (−0.019, 0.001) −0.009 (−0.019, 0.014) −0.008 (−0.017, 0.002) −0.002 (−0.018, 0.014)
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Table 5
The contemporaneous and lagged effects of internalized stigma and enacted stigma on instrumental social
support
Effect of internalized stigma on instrumental social
support Effect of enacted stigma on instrumental social support
Contemporaneous Lagged Contemporaneous Lagged
Variables b (95 % confidence interval
[CI])
b (95 % CI) b (95 % CI) b (95 % CI)
Intercept 3.53 (3.38, 3.67)*** 3.25 (3.06, 3.43)*** 3.58 (3.43, 3.72)*** 3.25 (3.07, 3.44)***
Internalized stigma −0.017 (−0.034, 0.000) – – –
Enacted stigma – – −0.11 (−0.14, −0.08)*** –
Lagged internalized stigma – −0.013 (−0.029, 0.004) – –
Lagged enacted stigma – – – −0.032 (−0.062, −0.001)*
Lagged instrumental social
support
– 0.083 (0.046, 0.119)*** – 0.084 (0.047, 0.120)***
Time −0.12 (−0.15, −0.08)*** −0.11 (−0.15, −0.08)*** −0.11 (−0.15, −0.07)*** −0.11 (−0.15, −0.077)***
Gender
 Male Ref Ref Ref Ref
 Female −0.16 (−0.25, −0.076)*** −0.15 (−0.24, −0.07)*** −0.15 (−0.24, −0.07)*** −0.15 (−0.23, −0.07)***
Age 0.001 (−0.004, 0.005) 0.0004 (−0.0004, 0.0047) 0.001 (−0.004, 0.005) 0.0006 (−0.004, 0.005)
Marital status
 Not married Ref Ref Ref Ref
 Married −0.028 (−0.094, 0.039) −0.032 (−0.096, 0.033) −0.03 (−0.096, −0.034) −0.026 (−0.090, 0.038)
Education
 No school Ref Ref Ref Ref
 Primary school or more 0.12 (0.02, 0.22)* 0.10 (0.008, 0.20)* 0.10 (0.004, 0.20)* 0.098 (0.0044, 0.19)*
Household asset wealth 0.082 (0.056, 0.11)*** 0.079 (0.053, 0.010)*** 0.075 (0.049, 0.10)*** 0.077 (0.052, 0.101)***
MOS-HIV Physical Health
Summary
0.004 (0.001, 0.007)** 0.004 (0.002, 0.007)** 0.003 (0.001, 0.006)* 0.004 (0.001, 0.007)**
CD4 (per 100 cells/mL) −0.032 (−0.048, −0.015)*** −0.030 (−0.046, −0.014)*** −0.032 (−0.048, −0.016)*** −0.032 (−0.048, −0.016)***
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